✦ LIBER ✦

DB2 PERSISTENCE WITH BASAL SUPPORTED ORAL THERAPY—COMPARISON OF INSULIN GLARGINE VERSUS NPH INSULIN

✍ Scribed by R Quinzler; M Ude; A Franzmann; S Feldt; K Leuner; WE Mueller; FW Dippel; M Schulz

Book ID: 118611734
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 78 KB
Volume: 12
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)74141-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk of exercise-induced hypoglycaemia i

Risk of exercise-induced hypoglycaemia in patients with type 2 diabetes on intensive insulin therapy: Comparison of insulin glargine with NPH insulin as basal insulin supplement

✍ Ursula Plöckinger; Mendaha Topuz; Brigitte Riese; Thomas Reuter 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 179 KB

PDB34 LOWER LONG-TERM COSTS IN GERMAN TY

PDB34 LOWER LONG-TERM COSTS IN GERMAN TYPE-2-DIABETICS STARTING A BASAL SUPPORTED ORAL THERAPY (BOT) WITH INSULIN GLARGINE COMPARED TO NPH-INSULIN

✍ W Kotowa; A Reichelt; M Pfohl; FW Dippel; O Pirk 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

Basal Supported Oral Therapy with Insuli

Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany

✍ Martin Pfohl; Franz-Werner Dippel; Karel Kostev; Sabine Fuchs; Wioletta Kotowa 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 441 KB

Comparison of Basal Insulin Added to Ora

Comparison of Basal Insulin Added to Oral Agents Versus Twice-Daily Premixed Insulin as Initial Insulin Therapy for Type 2 Diabetes

✍ Janka, H. U.; Plewe, G.; Riddle, M. C.; Kliebe-Frisch, C.; Schweitzer, M. A.; Yk 📂 Article 📅 2005 🏛 American Diabetes Association 🌐 English ⚖ 126 KB

PDB38 COST SAVINGS IN TYPE 2 DIABETES WI

PDB38 COST SAVINGS IN TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETEMIR IN A BASAL SUPPORTED ORAL THERAPY (BOT) IN GERMANY

✍ A Neilson; S Pscherer; FW Dippel; ES Dietrich 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PDB34 A COST-MINIMIZATION ANALYSIS FOR T

PDB34 A COST-MINIMIZATION ANALYSIS FOR TYPE 2 DIABETES WITH INSULIN GLARGINE COMPARED TO INSULIN DETERMIR IN A BASAL SUPPORTED ORAL THERAPY IN CHINA

✍ H Dong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB